Cargando…
Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism
Primary hyperparathyroidism (pHPT) is a common endocrine disorder. Often serum calcium is minimally elevated with few symptoms. In elderly patients with multiple co-morbidities, the decision to “watch and wait” is often most clinically appropriate as operative intervention is associated with high pe...
Autores principales: | Timmons, J. G., Manners, R., Bailey, M., McDougall, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357729/ https://www.ncbi.nlm.nih.gov/pubmed/33881757 http://dx.doi.org/10.1007/s42000-021-00292-4 |
Ejemplares similares
-
Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011) -
Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018) -
Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
por: Ng, Cheng Han, et al.
Publicado: (2020) -
Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
por: Nguyen, Son, et al.
Publicado: (2020) -
Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature
por: Vera, Lara, et al.
Publicado: (2016)